Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference14 articles.
1. Patel M, Harrison S, Sinclair R (2013) Drugs and hair loss. Dermatol Clin 31(1):67–73. https://doi.org/10.1016/j.det.2012.08.002
2. Chrétien B, Besnard A, Sassier M et al (2015) Rivaroxaban-induced hair loss. Eur J Clin Pharmacol 71(11):1413–1414. https://doi.org/10.1007/s00228-015-1927-7
3. Gelbricht V, Koehler C, Werth S et al (2012) Hair loss is a potential side effect of novel oral anticoagulants–findings from the Dresden Noac Registry (NCT01588119). Blood 120(21):1173–1173. https://doi.org/10.1182/blood.V120.21.1173.1173
4. Rivaroxaban, dabigatran and apixaban and possible risk of hair loss (alopecia) added to the medicines monitoring scheme. https://www.medsafe.govt.nz/safety/ews/2016/RivaroxabanDabigatranAndApixabanRiskofHairLoss.asp. Accessed April 10, 2020.
5. Bonaldo G, Vaccheri A, Motola D. Direct acting oral anticoagulants and alopecia: the valuable support of post marketing data. British Journal of Clinical Pharmacology. n/a(n/a). doi:10.1111/bcp.14221